摘要
目的 分析沙丁胺醇联合普米克令舒对小儿哮喘急性发作的治疗价值。方法 选取2014年1月-2016年1月在广东省恩平市妇幼保健院接受治疗的90例哮喘急性发作患儿作为研究对象,采用随机数字表法将其分为对照组和研究组,每组各45例。对照组患儿进行常规治疗,研究组患儿在此基础上使用沙丁胺醇联合普米克令舒治疗,分析两组患儿的治疗效果。结果 研究组患儿的总有效率（97.78%）与对照组（82.22%）比较,差异有统计学意义（P〈0.05）;研究组患儿的气促消退时间、咳嗽消退时间、憋喘消退时间、啰音消退时间分别为（3.92±1.56）、（8.42±1.36）、（4.78±1.35）、（7.68±1.65）d,与对照组患儿的（2.26±0.63）d、（6.24±1.03）d、（2.27±1.01）d、（5.36±1.04）d比较,差异有统计学意义（P〈0.05）;研究组患儿家长的治疗满意度（95.56%）与对照组（80.00%）比较,差异有统计学意义（P〈0.05）。结论 应用沙丁胺醇联合普米克令舒治疗小儿哮喘急性发作的效果较好。
Objective To explore and analyze the therapeutic value of Salbutamol combining with Pulmicort Respules in the treatment of children with acute asthma.Methods A total of 90 children with acute attack of asthma in Enping Maternal and Child Health Hospital of Guangdong Province from January 2014 to January 2016 were selected and divided into two groups according to the random number table,with 45 cases in each group.Patients in the control group were treated with routine therapy.In the research group,on the basis of the control group,Salbutamol together with Pulmicort Respules was added.The therapeutic effect in the two groups was analyzed.Results The total clinical effective rate in the research group was 97.78%,with a significant difference compared with that in the control group accounting for 82.22% （P〈0.05）.In the research group,disappearing time of shortage of breath,cough,panting,and tale was （3.92±1.56）, （8.42±1.36）,（4.78±1.35）,and （7.68±1.65） d,respectively,which was displayed a statistically significant difference compared with those in the control group [（2.26±0.63）,（6.24±1.03）,（2.27±1.01）,and （5.36±1.04） d] （P〈0.05）.The treatment satisfaction from children＇s parents was 95.56%,with a statistically significant difference in comparison with that in the control group （80.00%） （P〈0.05）.Conelusion Application of Salbutamol combining with Pulmieort Respules can obtain a favorable effect on treating children with acute asthma.
出处
《中国当代医药》
2016年第35期96-98,共3页
China Modern Medicine
关键词
沙丁胺醇
普米克令舒
小儿哮喘
急性发作
治疗价值
Salbutamol
Pulmicort Respules
Pediatric asthma
Acute attack
Therapeutic value
